Skip to main content
. 2023 May 13;30(7):701–709. doi: 10.5551/jat.RV22003

Table 2. Factor Ⅺ (a) inhibitors for thrombosis§ .

Small molecules Monoclonal antibodies Aptamers Antisense oligonucleotides Natural inhibitors
Mechanism of action Direct inhibition of FXIa Direct inhibition of FXI/FXIa Direct inhibition of FXIa Inhibition of FXI biosynthesis Direct inhibition of FXIa
Route of administration IV or Oral IV or SC IV or SC SC IV
Dosing Daily Monthly Daily Weekly Daily
Onset of action Minutes/Hours Hours Minutes/Hours Weeks Minutes
Offset of action Minutes/Hours Weeks Minutes/Hours Weeks Hours
Medication name Asundexian Osocimab FELIAP ISIS-FXIRx Fasxiator
Milvexian Abelacimab 29 nt 11.16 Fesomersen Ir-CPI
ONO-7684 Xisomab 40-nt 12.7
MK-2060

Abbreviations: IV, intravenous; SC, subcutaneous

§Table 2 adapted from [61].